Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence

Description

The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary outcome is social isolation.

Conditions

Endometrial Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary outcome is social isolation.

Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence

Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence

Condition
Endometrial Cancer
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama, Birmingham, Alabama, United States, 35294

Little Rock

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, 72205

Miami

University of Miami, Miami, Florida, United States, 33136

Chicago

The University of Chicago, Chicago, Illinois, United States, 60637

New Orleans

Louisiana State University - New Orleans, New Orleans, Louisiana, United States, 70112

Baltimore

Johns Hopkins University, Baltimore, Maryland, United States, 21218

Columbia

MedStar Health Research Institute, Columbia, Maryland, United States, 21044

New York

Weill Cornell Medicine, New York, New York, United States, 10021

Chapel Hill

University of North Carolina, Chapel Hill, North Carolina, United States, 27599

Seattle

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States, 98105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adult 18 years of age or older; and
  • 2. Self-identify as Black/African American
  • 3. Presenting with high-risk EC established by anatomic pathology as tumor stage and grade classification by the following:
  • 1. Pathology documentation from any hospital/clinic/medical center, and
  • 2. FIGO Stage 1A with Grade 2, Grade 3, or Grade 4 of any histology type or
  • 3. FIGO Stage 1A with non-endometrioid (carcinosarcoma, serous, clear cell, undifferentiated or mixed) histology
  • 4. FIGO Stage 1B, 2, 3, or 4 of any grade or histology
  • 5. Recurrent endometrial cancer of any stage or grade
  • 4. Documented provider recommendation and patient plan to initiate adjuvant therapy with chemotherapy, radiation, and/or immunotherapy.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Washington,

Kemi M Doll, MD, MS, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

2026-03-30